
Hubei
300966.SZHubei Goto Biopharm Co.,Ltd. Price (300966.SZ)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
115,025,074
(0.2185)%Revenue and Profitability
Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Revenue | 333,692,153 | 437,301,668 | 464,801,920 | 468,117,263 | 590,885,338 | 604,571,473 | 566,399,208 |
Net Income | 47,438,680 | 70,677,875 | 72,996,358 | 53,288,521 | 78,330,635 | 40,205,160 | 23,005,014 |
FCF USD | -41,729,803 | -61,801,973 | -24,767,765 | -5,092,010 | -32,872,088 | -431,976,652 | -341,122,039 |
OCF USD | -22,059,686 | -47,892,814 | 8,502,366 | 13,474,987 | 58,004,300 | -24,036,809 | 68,132,538 |
Financial Health - DEBT
Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
YTPD | 0.00 | 0.11 | 0.43 | 0.02 | 0.09 | 11.18 | 28.38 |
D/E | 0.19 | 0.20 | 0.31 | 0.26 | 0.20 | 0.83 | 0.80 |
CA/CL | 1.70 | 2.25 | 1.98 | 2.35 | 2.58 | 2.11 | 1.27 |
TA/TL | 2.64 | 2.97 | 2.43 | 3.04 | 3.16 | 1.90 | 1.72 |
Total Debt | 55,950,000 | 80,896,084 | 147,320,697 | 139,765,166 | 161,541,392 | 770,301,970 | 763,005,145 |
Management Performance
Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
ROIC | 12.98% | 13.63% | 9.90% | 7.26% | 5.57% | 2.20% | 1.16% |
ROE | 15.79% | 17.31% | 15.17% | 9.97% | 9.71% | 4.33% | 2.41% |
ROA | 0.00% | 11.49% | 8.93% | 6.61% | 6.45% | 1.91% | 0.94% |
NM % | 14.22% | 16.16% | 15.70% | 11.38% | 13.26% | 6.65% | 4.06% |
FCF / R% | 0.00% | -14.13% | -5.33% | -1.09% | -5.56% | -71.45% | -60.23% |
FCF / NI% | -87.97% | -87.44% | -33.93% | -9.57% | -42.11% | -1,093.72% | -1,482.82% |
Operating Margin (OM) | 0.00 | 0.17 | 0.31 | 0.42 | 0.46 | 0.49 | 0.57 |
Per Share
Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
EPS | 1.03 | 0.84 | 0.63 | 0.46 | 0.68 | 0.35 | 0.20 |
SPS | 7.25 | 5.20 | 4.03 | 4.06 | 5.13 | 5.24 | 4.92 |
OCPS | -0.48 | -0.57 | 0.07 | 0.12 | 0.50 | -0.21 | 0.59 |
FCPS | -0.91 | -0.73 | -0.21 | -0.04 | -0.29 | -3.75 | -2.97 |
BVPS | 6.52 | 4.85 | 4.17 | 4.68 | 7.19 | 8.51 | 8.90 |
Per Share - CAGR
Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
CAGR-EPS | 1.03 | 0.84 | 0.63 | 0.46 | 0.68 | 0.35 | 0.20 |
CAGR-SPS | 7.25 | 5.20 | 4.03 | 4.06 | 5.13 | 5.24 | 4.92 |
CAGR-OCPS | -0.48 | -0.57 | 0.07 | 0.12 | 0.50 | -0.21 | 0.59 |
CAGR-FCPS | -0.91 | -0.73 | -0.21 | -0.04 | -0.29 | -3.75 | -2.97 |
CAGR-BVPS | 6.52 | 4.85 | 4.17 | 4.68 | 7.19 | 8.51 | 8.90 |